PhagoMed selected for EIT Gold Track program

PhagoMed has been selected as one of just five European Lifescience Scale-ups to participate in the current cohort of the EIT Gold Track program.

In a highly competitive process led by an Expert Council of successful entrepreneurs, Biotech venture capitalists and top industry executives, the company successfully demonstrated its capacity for rapid scalability and top-notch innovation. EIT Health and the Gold Track team will now support PhagoMed in achieving its business goals. As part of the Gold Track program, the company will benefit from tailored mentoring as well as matchmaking with leading investors and industry partners around the world.

The Gold Track program selects between 10 and 15 European Lifescience companies every year. These companies receive world-class mentoring and tailor-made exposure to potential investors and industry partners around the world. For more information on the Gold Track program, please follow this link.

PhagoMed Biopharma GmbH
Leberstraße 20
1110 Vienna, Austria

The sender takes full responsibility for the content of this news item. Content may include forward-looking statements which, at the time they were made, were based on expectations of future events. Readers are cautioned not to rely on these forward-looking statements.

As a life sciences organization based in Vienna, would you like us to promote your news and events? If so, please send your contributions to news(at)